Jenyne Engelhardt helps lead FleishmanHillard’s healthcare team, bringing extensive experience with therapeutic categories covering nutrition, OTC’s, cardiology, gastroenterology, obesity and pain management. She also specializes in product launches, public health awareness and consumer education. Engelhardt, who led the FDA approval of BELVIQ – the first weight-loss drug to be approved by the FDA in over a decade – received the 2000 Rising Star Award from the Healthcare Businesswomen’s Association.
Blog Posts by Jenyne Engelhardt
No Roar From Pharma at Cannes Lions Health June 15, 2014